Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice (Q74127893)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

N Cartier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

S Guidoux

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F Rocchiccioli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Aubourg

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

205-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDRP), a peroxisomal ABC transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Primary structure of human PMP69, a putative peroxisomal ABC-transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Identification of a fourth half ABC transporter in the human peroxisomal membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Lovastatin for X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Retroviral transfer and long-term expression of the adrenoleukodystrophy gene in human CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

A mouse model for X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

Differential effects of lovastatin on the trafficking of endogenous and lipoprotein-derived cholesterol in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901852-4

10.1016/S0014-5793(00)01852-4

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930569%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference